IgG4-related kidney disease and retroperitoneal fibrosis: An update

References

• Nakashima H, Kawano M, Saeki T, Ubara Y, Hisano S, Nagata M, et al. Estimation of the number of histological diagnosis for IgG4-related kidney disease referred to the data obtained from the Japan Renal Biopsy Registry (J-RBR) questionnaire and cases reported in the Japanese Society of Nephrology Meetings. Clin Exp Nephrol. 2017;21(1):97–103.
   PubMed Web of Science ®Google Scholar
• Yamada K, Yamamoto M, Saeki T, Mizushima I, Matsui S, Fujisawa Y, et al. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Res Ther. 2017;19:262.
   PubMed Web of Science ®Google Scholar
• Inoue D, Yoshida K, Yoneda N, Ozaki K, Matsubara T, Nagai K, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015;94(15):e680.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhao JZ, Feng RE, Shi JH, Li XM, Fei YY, et al. Types of organ involvement in patients with immunoglobulin G4-related disease. Chin Med J. 2016;129(13):1525–32.
   PubMed Web of Science ®Google Scholar
• Sekiguchi H, Horie R, Kanai M, Suzuki R, Yi ES, Ryu JH. IgG4-related disease: retrospective analysis of one hundred sixty-six patients. Arthritis Rheumatol. 2016;68(9):2290–9.
   PubMed Web of Science ®Google Scholar
• Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, Stone JH. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 2015;67(9):2466–75.
   PubMed Web of Science ®Google Scholar
• Lin W, Lu S, Chen H, Wu Q, Fei Y, Li M, et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology (Oxford). 2015;54(11):1982–90.
   PubMed Web of Science ®Google Scholar
• Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34(12):1812–9.
   PubMed Web of Science ®Google Scholar
• Fernández-Codina A, Martínez-Valle F, Pinilla B, López C, DeTorres I, Solans-Laqué R, et al. IgG4-related disease: results from a multicenter Spanish Registry. Medicine (Baltimore). 2015;94(32):e1275.
   PubMed Web of Science ®Google Scholar
• Saeki T, Nishi S, Imai N, Ito T, Yamazaki H, Kawano M, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010;78(10):1016–23.
   PubMed Web of Science ®Google Scholar
• Kawano M, Saeki T, Nakashima H, Nishi S, Yamaguchi Y, Hisano S, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15(5):615–26.
   PubMed Web of Science ®Google Scholar
• Raissian Y, Nasr SH, Larsen CP, Colvin RB, Smyrk TC, Takahashi N, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011;22(7):1343–52.
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Kanetsuna Y, Honda K, Yamanaka N, Kawano M, Nagata M, et al. Characteristic tubulointerstitial nephritis in IgG4-related disease. Hum Pathol. 2012;43(4):536–49.
   PubMed Web of Science ®Google Scholar
• Kawano M, Mizushima I, Yamaguchi Y, Imai N, Nakashima H, Nishi S, et al. Immunohistochemical characteristics of IgG4-related tubulointerstitial nephritis: detailed analysis of 20 Japanese cases. Int J Rheumatol. 2012;2012:1.
   Google Scholar
• Kawano M, Saeki T. IgG4-related kidney disease-an update. Curr Opin Nephrol Hypertens. 2015;24(2):193–201.
   PubMed Web of Science ®Google Scholar
• Morimoto J, Hasegawa Y, Fukushima H, Uesugi N, Hisano S, Saito T, et al. Membranoproliferative glomerulonephritis-like glomerular disease and concurrent tubulointerstitial nephritis complicating IgG4-related autoimmune pancreatitis. Intern Med. 2009;48(3):157–62.
   PubMed Web of Science ®Google Scholar
• Saeki T, Imai N, Ito T, Yamazaki H, Nishi S. Membranous nephropathy associated with IgG4-related systemic disease and without autoimmune pancreatitis. Clin Nephrol. 2009;71(2):173–8.
   PubMed Web of Science ®Google Scholar
• Katano K, Hayatsu Y, Matsuda T, Miyazaki R, Yamada K, Kawano M, et al. Endocapillary proliferative glomerulonephritis with crescent formation and concurrent tubulointerstitial nephritis complicating retroperitoneal fibrosis with a high serum level of IgG4. Clin Nephrol. 2007;68(11):308–14.
   PubMedGoogle Scholar
• Tamai R, Hasegawa Y, Hisano S, Miyake K, Nakashima H, Saito T. A case of IgG4-related tubulointerstitial nephritis concurrent with Henoch-Schönlein purpura nephritis. Allergy Asthma Clin Immunol. 2011;7(1):5.
   PubMedGoogle Scholar
• Ito K, Yamada K, Mizushima I, Aizu M, Fujii H, Mizutomi K, et al. Henoch-Schönlein purpura nephritis in a patient with IgG4-related disease: a possible association. Clin Nephrol. 2013;79(03):246–52. Mar
   PubMedGoogle Scholar
• Okuyama Y, Uchida HA, Tenta M, Nunoue T, Umebayashi R, Morinaga H, et al. Autoimmune pancreatitis and minimal change nephrotic syndrome: an unusual association?. Nephrology (Carlton). 2015;20(3):225–6.
   PubMed Web of Science ®Google Scholar
• Yamada K, Zoshima T, Ito K, Mizushima I, Hara S, Horita S, et al. A case developing minimal change disease during the course of IgG4-related disease. Mod Rheumatol. 2017;27(4):712–5.
   PubMed Web of Science ®Google Scholar
• Alexander MP, Larsen CP, Gibson IW, Nasr SH, Sethi S, Fidler ME, et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int. 2013;83(3):455–62.
   PubMed Web of Science ®Google Scholar
• Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64(10):3061–7.
   PubMed Web of Science ®Google Scholar
• Kim SA, Lee SR, Huh J, Shen SS, Ro JY. IgG4-associated inflammatory pseudotumor of ureter: clinicopathologic and immunohistochemical study of 3 cases. Hum Pathol. 2011;42(8):1178–84.
   PubMed Web of Science ®Google Scholar
• Marando A, D'Ambrosio G, Catanzaro F, La Rosa S, Sessa F. IgG4-related disease of the ureter: report of two cases and review of the literature. Virchows Arch. 2013;462(6):673–8.
   PubMed Web of Science ®Google Scholar
• Mizushima I, Inoue D, Kawano M. Retroperitoneal fibrosis/periaortitis and hydronephrosis. In: Saito T, Stone JH, Nakashima H, Saeki T, Kawano M, editors. IgG4-Related Kidney Disease. Tokyo: Springer; 2016. p. 159–71.
   Google Scholar
• Saeki T, Kobayashi D, Ito T, Tamura M, Yoshikawa S, Yamazaki H. Comparison of clinical and laboratory features of patients with and without allergic conditions in IgG4-related disease: a single-center experience in Japan. Mod Rheumatol. 2018;28(5):845–8.
   PubMed Web of Science ®Google Scholar
• Sato Y, Kojima M, Takata K, Morito T, Mizobuchi K, Tanaka T, et al. Multicentric Castleman’s disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases. J Clin Pathol. 2010;63(12):1084–9.
   PubMed Web of Science ®Google Scholar
• Muraki T, Hamano H, Ochi Y, Komatsu K, Komiyama Y, Arakura N, et al. Autoimmune pancreatitis and complement activation system. Pancreas 2006;32(1):16–21.
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Watanabe H, Asano T, Sato S, Takagi T, Kobayashi H, et al. Possible participation of IgG4 in the activation of complement in IgG4-related disease with hypocomplementemia. Mod Rheumatol. 2016;26(2):251–8.
   PubMed Web of Science ®Google Scholar
• Shiokawa M, Kodama Y, Sekiguchi K, Kuwada T, Tomono T, Kuriyama K, et al. Laminin 511 is a target antigen in autoimmune pancreatitis. Sci Transl Med. 2018;10(453):pii–eaaq0997. Aug 8. doi: 10.1126/scitranslmed.aaq0997.
   Web of Science ®Google Scholar
• Saeki T, Kawano M, Mizushima I, Yamamoto M, Wada Y, Nakashima H, et al. The clinical course of patients with IgG4-related kidney disease. Kidney Int. 2013;84(4):826–33.
   PubMed Web of Science ®Google Scholar
• Takahashi N, Kawashima A, Fletcher JG, Chari ST. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 2007;242(3):791–801.
   PubMed Web of Science ®Google Scholar
• Horita S, Fujii H, Mizushima I, Fujisawa Y, Hara S, Yamada K, et al. A case of IgG4-related tubulointerstitial nephritis and membranous glomerulonephritis during the clinical course of gastric cancer: imaging features of IgG4-related kidney disease. Mod Rheumatol. 2016;27:1–5. [Epub ahead of print]
   Google Scholar
• Inoue D, Kawano M, Yamada K. Kidney and urinary tract lesions. In: Umehara H, Okazaki K, Stone JH, Kawa S, Kawano M, editors. IgG4-Related Disease. Tokyo: Springer Japan; 2014. p. 99–105.
   Google Scholar
• Inoue K, Okubo T, Kato T, Shimamura K, Sugita T, Kubota M, et al. IgG4-related stomach muscle lesion with a renal pseudotumor and multiple renal rim-like lesions: a rare manifestation of IgG4-related disease. Mod Rheumatol. 2018;28(1):188–92.
   PubMed Web of Science ®Google Scholar
• Kawano M, Yamada K. IgG4-related kidney disease and IgG4-related retroperitoneal fibrosis. Semin Liver Dis. 2016;36:283–90.
   PubMed Web of Science ®Google Scholar
• Cho YJ, Jung WY, Lee SY, Song JS, Park HJ. Perirenal capsule and scrotal involvement in immunoglobulin G4-related kidney disease: case-based review. Rheumatol Int. 2018;38(10):1941–8.
   PubMed Web of Science ®Google Scholar
• Bianchi D, Topazio L, Gaziev G, Iacovelli V, Bove P, Mauriello A, et al. IgG4-related kidney disease: report of a case presenting as a renal mass. Case Rep Surg. 2017;2017:9690218.
   PubMedGoogle Scholar
• Shoji S, Nakano M, Usui Y. IgG4-related inflammatory pseudotumor of the kidney. Int J Urol. 2010;17(4):389–90.
   PubMed Web of Science ®Google Scholar
• Cai YI, Li HZ, Zhang YS. IgG4-related inflammatory pseudotumor of the kidney mimicking renal cell carcinoma: a case report. Oncol Lett. 2016;11(5):3438–40.
   PubMed Web of Science ®Google Scholar
• Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181–92.
   PubMed Web of Science ®Google Scholar
• Yoshita K, Kawano M, Mizushima I, Hara S, Ito Y, Imai N, et al. Light-microscopic characteristics of IgG4-related tubulointerstitial nephritis: distinction from non-IgG4-related tubulointerstitial nephritis. Nephrol Dial Transplant. 2012;27(7):2755–61.
   PubMed Web of Science ®Google Scholar
• Khosroshahi A, Ayalon R, Beck LH Jr, Salant DJ, Bloch DB, Stone JH. IgG4-related disease is not associated with antibody to the phospholipase A2 receptor. Int J Rheumatol. 2012;2012:139409.
   PubMedGoogle Scholar
• Miyata KN, Kihira H, Haneda M, Nishio Y. IgG4-related tubulointerstitial nephritis associated with membranous nephropathy in two patients: remission after administering a combination of steroid and mizoribine. Case Rep Nephrol. 2014;2014:678538.
   PubMedGoogle Scholar
• Zen Y, Fujii T, Harada K, Kawano M, Yamada K, Takahira M, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007;45(6):1538–46.
   PubMed Web of Science ®Google Scholar
• Hara S, Kawano M, Mizushima I, Harada K, Takata T, Saeki T, et al. Distribution and components of interstitial inflammation and fibrosis in IgG4-related kidney disease: analysis of autopsy specimens. Hum Pathol. 2016;55:164–73.
   PubMed Web of Science ®Google Scholar
• Sharma SG, Vlase HL, D'Agati VD. IgG4-related tubulointerstitial nephritis with plasma cell-rich renal arteritis. Am J Kidney Dis. 2013;61(4):638–43.
   PubMed Web of Science ®Google Scholar
• Notohara K, Kamisawa T, Uchida K, Zen Y, Kawano M, Kasashima S, et al. Gastrointestinal manifestation of immunoglobulin G4-related disease: clarification through a multicenter survey. J Gastroenterol. 2018;53(7):845–53.
   PubMed Web of Science ®Google Scholar
• Fujii M, Sato Y, Ohara N, Hashimoto K, Kobashi H, Koyama Y, et al. Systemic IgG4-related disease with extensive peripheral nerve involvement that progressed from localized IgG4-related lymphadenopathy: an autopsy case. Diagn Pathol. 2014;9(1):41.
   PubMedGoogle Scholar
• Harada K, Ubara Y, IgG4-related kidney diseases and conditions: renal pelvic and ureteral diseases. In: Saito T, Stone JH, Nakashima H, Saeki T, Kawano M, editors. IgG4-Related Kidney Disease. Tokyo: Springer; 2016. p. 145–57.
   Google Scholar
• Inenaga J, Ueno T, Kawada M, Imafuku A, Mise K, Sumida K, et al. IgG4-related disease: a mass lesion in the intrarenal sinus near the renal pelvis. Intern Med. 2015;54(15):1897–900.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Takahashi H, Suzuki C, Tabeya T, Ohara M, Naishiro Y, et al. Analysis of serum IgG subclasses in Churg-Strauss syndrome-the meaning of elevated serum levels of IgG4. Intern Med. 2010;49(14):1365–70.
   PubMed Web of Science ®Google Scholar
• Chang SY, Keogh KA, Lewis JE, Ryu JH, Cornell LD, Garrity JA, et al. IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener’s): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases. Hum Pathol. 2013;44(11):2432–7.
   PubMed Web of Science ®Google Scholar
• Della-Torre E, Lanzillotta M, Campochiaro C, Bozzalla E, Bozzolo E, Bandiera A, et al. Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: a case report and review of the literature. Medicine (Baltimore). 2016;95(34):e4633.
   PubMed Web of Science ®Google Scholar
• Danlos FX, Rossi GM, Blockmans D, Emmi G, Kronbichler A, Durupt S, et al. Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome. Autoimmun Rev. 2017;16(10):1036–43.
   PubMed Web of Science ®Google Scholar
• van Rhee F, Voorhees P, Dispenzieri A, Fosså A, Srkalovic G, Ide M, et al. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood 2018;132(20):2115–24.
   PubMed Web of Science ®Google Scholar
• Otani K, Inoue D, Fujikura K, Komori T, Abe-Suzuki S, Tajiri T, et al. Idiopathic multicentric Castleman’s disease: a clinicopathologic study in comparison with IgG4-related disease. Oncotarget 2018;9:6691–706.
   PubMedGoogle Scholar
• Xu D, Lv J, Dong Y, Wang S, Su T, Zhou F, et al. Renal involvement in a large cohort of Chinese patients with Castleman disease. Nephrol Dial Transplant. 2012;27(suppl_3):iii119–25.
   PubMedGoogle Scholar
• Takeuchi M, Sato Y, Takata K, Kobayashi K, Ohno K, Iwaki N, et al. Cutaneous multicentric Castleman’s disease mimicking IgG4-related disease. Pathol Res Pract. 2012;208(12):746–9.
   PubMed Web of Science ®Google Scholar
• Ogoshi T, Kido T, Yatera K, Oda K, Kawanami T, Ishimoto H, et al. Assessment of pathologically diagnosed patients with Castleman’s disease associated with diffuse parenchymal lung involvement using the diagnostic criteria for IgG4-related disease. Lung 2013;191(6):575–83.
   PubMed Web of Science ®Google Scholar
• Zoshima T, Yamada K, Hara S, Mizushima I, Yamagishi M, Harada K, et al. Multicentric castleman disease with tubulointerstitial nephritis mimicking IgG4-related disease: two case reports. Am J Surg Pathol. 2016;40(4):495–501.
   PubMed Web of Science ®Google Scholar
• Ozaki K, Miyayama S, Ushiogi Y, Matsui O. Renal involvement of polyarteritis nodosa: CT and MR findings. Abdom Imaging. 2009;34(2):265–70.
   PubMedGoogle Scholar
• Saito T, Differential diagnosis (3): Sjogren’s syndrome. In: Saito T, Stone JH, Nakashima H, Saeki T, Kawano M, editors. IgG4-Related Kidney Disease. Tokyo: Springer; 2016. p. 271–277.
   Google Scholar
• Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67(7):1688–99.
   PubMed Web of Science ®Google Scholar
• Mizushima I, Yamada K, Fujii H, Inoue D, Umehara H, Yamagishi M, et al. Clinical and histological changes associated with corticosteroid therapy in IgG4-related tubulointerstitial nephritis. Mod Rheumatol. 2012;22(6):859–70.
   PubMed Web of Science ®Google Scholar
• Saeki T, Kawano M, Mizushima I, Yamamoto M, Wada Y, Ubara Y, et al. Recovery of renal function after glucocorticoid therapy for IgG4-related kidney disease with renal dysfunction. Clin Exp Nephrol. 2016;20(1):87–93.
   PubMed Web of Science ®Google Scholar
• Iguchi T, Takaori K, Mii A, Sato Y, Suzuki Y, Yoshifuji H, et al. Glucocorticoid receptor expression in resident and hematopoietic cells in IgG4-related disease. Mod Pathol. 2018;31(6):890–9.
   PubMed Web of Science ®Google Scholar
• Mizushima I, Yamamoto M, Inoue D, Nishi S, Taniguchi Y, Ubara Y, et al. Factors related to renal cortical atrophy development after glucocorticoid therapy in IgG4-related kidney disease: a retrospective multicenter study. Arthritis Res Ther. 2016;18:273.
   PubMed Web of Science ®Google Scholar
• Takeji A, Yamada K, Inoue D, Mizushima I, Hara S, Ito K, et al. A case of IgG4-related kidney disease with predominantly unilateral renal atrophy. CEN Case Rep. 2018. doi:10.1007/s13730-018-0355-9. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Nishi H, Shibagaki Y, Hirano K, Akahane M, Kido R, Nangaku M, et al. Laboratory and imaging features of kidney involvement in autoimmune pancreatitis: incidence, correlation, and steroid therapy response. Clin Nephrol. 2010;73(4):253–9.
   PubMed Web of Science ®Google Scholar
• Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015;74(6):1171–7.
   PubMed Web of Science ®Google Scholar
• Wallace ZS, Mattoo H, Mahajan VS, Kulikova M, Lu L, Deshpande V, et al. Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology (Oxford). 2016;55(6):1000–8.
   PubMed Web of Science ®Google Scholar
• McMahon BA, Novick T, Scheel PJ, Bagnasco S, Atta MG. Rituximab for the treatment of IgG4-related tubulointerstitial nephritis: case report and review of the literature. Medicine (Baltimore). 2015;94(32):e1366.
   PubMed Web of Science ®Google Scholar